The IER5 Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-mediated gene disruption model designed to abrogate IER5 expression in HeLa cells. This polyclonal population is generated by non-clonal expansion of edited cells, yielding a heterogeneous knockout pool that avoids biases associated with monoclonal selection. It provides a versatile loss-of-function tool for investigating IER5-dependent signaling in a well-characterized epithelial cancer cell line. Researchers can utilize this product to probe gene function in pathways relevant to stress responses and oncogenesis.
The HeLa host cell line is an immortalized human cervical epithelial adenocarcinoma model containing integrated human papillomavirus type 18 (HPV18) sequences. Derived from a cervical carcinoma, HeLa cells are extensively employed in cancer biology, signal transduction, and drug discovery due to their robust proliferation and well-annotated molecular landscape. Their HPV-positive status renders them especially pertinent for studying cervical carcinogenesis and host?Cvirus interactions that influence tumor progression.
IER5, an immediate early gene, encodes a transcriptional regulator centrally involved in the cellular heat shock response. Its expression is rapidly upregulated by serum, epidermal growth factor (EGF), platelet-derived growth factor (PDGF), phorbol ester (TPA), and mechanical stress, primarily via ERK1/2-dependent signaling cascades. Upon induction, IER5 directly interacts with heat shock factor 1 (HSF1) and its associated transcriptional cofactors to modulate the expression of HSP70 and other heat shock proteins. This molecular circuitry translates mitogenic and stress stimuli into adaptive transcriptional programs that govern stress tolerance and cell proliferation.
In the context of HeLa cells, where HPV18 oncoproteins drive dysregulated MAPK/ERK activity, IER5 likely serves as a key integrator of oncogenic and environmental signals. The polyclonal knockout of IER5 enables systematic dissection of its contributions to stress-mediated transcriptional control, proliferation, and survival in a cervical carcinoma background. Furthermore, the model is relevant to hepatocellular carcinoma research, given the reported implication of IER5 in this cancer type, supporting cross-tumor comparative functional studies.
These polyclonal cells support western blotting, RT-qPCR, immunofluorescence, apoptosis and proliferation assays, and HSF1 reporter analyses. They are appropriate for functional genomics screens, drug response profiling, and detailed signaling studies under serum, growth factor, or thermal stress conditions. For additional information, contact Ascent Research.
